Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

NACompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

March 27, 2018

Primary Completion Date

July 1, 2020

Study Completion Date

December 31, 2020

Conditions
Pathologic Myopia
Interventions
PROCEDURE

Intravitreal injection

Intravitreal injection to the regimen pro re nata.

Trial Locations (3)

54000

Mykolaiv Region Ophthalmogical Hospital, Mykolaiv

65028

Odessa National Medical University, Odesa

65061

The Filatov Institute of Eye Diseases and Tissue Therapy, Odesa

All Listed Sponsors
collaborator

Odessa National Medical University

OTHER

collaborator

Mykolaiv Region Ophthalmogical Hospital

OTHER

collaborator

Central Polyclinic of Internal Affairs of Ukraine

OTHER_GOV

lead

The Filatov Institute of Eye Diseases and Tissue Therapy

OTHER

NCT03963596 - Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia | Biotech Hunter | Biotech Hunter